nach oben

Quality of Life Research

Erschienen in:

01.09.2009

Reliability and validity of an instrument for assessing patients’ perceptions about medications for diabetes: the PAM-D

verfasst von: Patrick O. Monahan, Kathleen A. Lane, Risa P. Hayes, Colleen A. McHorney, David G. Marrero

Erschienen in: Quality of Life Research | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the reliability and validity of the Perceptions About Medications for Diabetes (PAM-D) instrument.

Methods

The item pool was generated from a literature review and 18 focus groups of Type 2 diabetes patients. Surveys were mailed to 1,000 low-income diabetes patients; 362 were returned; 65 of 100 re-test surveys were returned.

Results

This paper uses data from 343 Type 2 respondents. Mean age and age diagnosed were 59 and 48, respectively; 72% female; 52% African American; 51% were taking oral antihyperglycemic agents [OHA] monotherapy, 18% insulin monotherapy, and 28% insulin plus OHA. The initial 66 items were reduced to 37 across nine scales: scheduling flexibility, portability convenience, regimen inconvenience, medication effectiveness, difficulty remembering medications, gastrointestinal, hypoglycemia-related, and weight/edema physical side effects, and emotional side effects. Scale reliabilities ranged from 0.71 to 0.92 (coefficient alpha) and from 0.54 to 0.83 (test–retest coefficient, 37–81-day interval); factor loadings ranged from 0.35 to 0.86 (median, 0.67); significant scale differences across medication groups (insulin, OHA, insulin plus OHA) were consistent with a priori hypotheses.

Conclusions

The PAM-D has substantial reliability and validity in a low-income, inner-city population of Type 2 diabetes patients and may be valuable for understanding multidimensional perceptions driving patients’ treatment preferences.

Aristides, M., Weston, A. R., FitzGerald, P., Le Reun, C., & Maniadakis, N. (2004). Patient preference and willingness-to-pay for Humalog Mix25 relative to Humulin 30/70: A multicountry application of a discrete choice experiment. Value in Health, 7(4), 442–454.PubMedCrossRef

Rubin, R. R., & Peyrot, M. (2004). Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care, 27(10), 2495–2497. Erratum in Diabetes Care. 2004 Dec;2427(2412):3032.PubMedCrossRef

Cappelleri, J. C., Cefalu, W. T., Rosenstock, J., Kourides, I. A., & Gerber, R. A. (2002). Treatment satisfaction in Type 2 diabetes: A comparison between an inhaled insulin regimen and a subcutaneous insulin regimen. Clinical Therapeutics, 24(4), 552–564.PubMedCrossRef

Witthaus, E., Stewart, J., & Bradley, C. (2001). Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes. Diabetic Medicine, 18(8), 619–625.PubMedCrossRef

Anderson, R. T., Skovlund, S. E., Marrero, D., et al. (2004). Development and validation of the insulin treatment satisfaction questionnaire. Clinical Therapeutics, 26(4), 565–578.PubMedCrossRef

Cappelleri, J. C., Gerber, R. A., Kourides, I. A., & Gelfand, R. A. (2000). Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for Type 1 diabetes. Diabetes Care, 23(12), 1799–1803.PubMedCrossRef

Lewis, K. S., Bradley, C., Knight, G., Boulton, A. J., & Ward, J. D. (1988). A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabetic Medicine, 5(3), 235–242.PubMedCrossRef

Hayes, R. P., Bowman, L., Monahan, P. O., Marrero, D. G., & McHorney, C. A. (2006). Understanding diabetes medications from the perspective of patients with Type 2 diabetes: Prerequisite to medication concordance. The Diabetes Educator, 32(3), 404–414.PubMedCrossRef

Shikiar, R., & Rentz, A. M. (2004). Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value in Health, 7(2), 204–215.PubMedCrossRef

10.

Brod, M., Cobden, D., Lammert, M., Bushnell, D., & Raskin, P. (2007). Examining correlates of treatment satisfaction for injectable insulin in Type 2 diabetes: Lessons learned from a clinical trial comparing biphasic and basal analogues. Health and Quality of Life Outcomes, 5, 8.PubMedCrossRef

11.

Horne, R., & Weinman, J. (1999). Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47(6), 555–567.PubMedCrossRef

12.

Gordon, K., Smith, F., & Dhillon, S. (2007). Effective chronic disease management: Patients’ perspectives on medication-related problems. Patient Education and Counseling, 65(3), 407–415.PubMedCrossRef

13.

Phatak, H. M., & Thomas, J., III. (2006). Relationships between beliefs about medications and nonadherence to prescribed chronic medications. The Annals of Pharmacotherapy, 40(10), 1737–1742.PubMedCrossRef

14.

Ross, S., Walker, A., & MacLeod, M. J. (2004). Patient compliance in hypertension: Role of illness perceptions and treatment beliefs. Journal of Human Hypertension, 18(9), 607–613.PubMedCrossRef

15.

McHorney, C. A., Schousboe, J. T., Cline, R. R., & Weiss, T. W. (2007). The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Current Medical Research and Opinion, 23(12), 3137–3152.PubMedCrossRef

16.

McHorney, C. A., Hayes, R., Bowman, L., & Myers, J. (2004). Drivers of treatment preference among patients with Type 2 diabetes. Paper presented at: ISPOR ninth annual international meeting, Arlington, VA, USA, May 16–19. Available at http://www.biostat.iupui.edu/Faculty/monahan.aspx.

17.

Berelson, B. (1954). Content analysis. In G. Lindzey (Ed.), Handbook of social psychology (pp. 488–518). Reading, MA: Addison-Wesley.

18.

Aday, L. A., & Cornelius, L. J. (2006). Designing and conducting health surveys: A comprehensive guide (3rd ed.). San Francisco: Jossey-Bass.

19.

Carter, J. S., Pugh, J. A., & Monterrosa, A. (1996). Non-insulin dependent diabetes mellitus in minorities in the United States. Annals of Internal Medicine, 125(3), 221–232.PubMed

20.

Karter, A. J., Stevens, M. R., Herman, W. H., et al. (2003). Out-of-pocket costs and diabetes preventive services: The Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care, 26(8), 2294–2299.PubMedCrossRef

21.

Pogach, L. M., Hawley, G., Weinstock, R., et al. (1994). Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994). Use of an ambulatory care pharmacy-derived database. Diabetes Care, 21(3), 368–373.CrossRef

22.

Koro, C. E., Bowlin, S. J., Bourgeois, N., & Fedder, D. O. (2004). Glycemic control from 1988 to 2000 among U.S. adults diagnosed with Type 2 diabetes: A preliminary report. Diabetes Care, 27(1), 17–20.PubMedCrossRef

23.

McHorney, C. A., Ware, J. E., Lu, J. F. R., & Sherbourne, C. D. (1994). The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Medical Care, 32(1), 40–66.PubMedCrossRef

24.

Zwick, R., & Velicer, W. F. (1986). Comparison of five rules for determining the number of components to retain. Psychological Bulletin, 99(3), 432–442.CrossRef

25.

Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York: McGraw-Hill.

26.

Stewart, A. L., & Ware, J. E. (1992). Measuring functioning and well-being: The medical outcomes study approach. Durham, NC: Duke University Press.

27.

Howard, K. I., & Forehand, G. A. (1962). A method for correcting item-total correlations for the effect of relevant item inclusion. Educational and Psychological Measurement, 22(4), 731–735.CrossRef

28.

Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef

29.

McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods, 1(1), 30–46.CrossRef

30.

Hayes, C., & Bowman, L. (2003). Reliability and validity of the treatment flexibility scale. Quality of Life Research, 12, 863.

31.

Hayter, A. J. (1986). The maximum familywise error rate of Fisher’s least significant difference test. Journal of the American Statistical Association, 81(396), 1000–1004.CrossRef

32.

Barnett, A. H., Jones, D. B., Burden, A. C., et al. (1996). Multicentre study to assess quality of life and glycaemic control of Type 2 diabetic patients treated with insulin compared with oral hypoglycaemic agents. Practical Diabetes International, 13(6), 179–183.CrossRef

33.

Bradley, C. (1999). Diabetes treatment satisfaction questionnaire: Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care, 22(3), 530–532.PubMedCrossRef

34.

Howorka, K., Pumprla, J., Wagner-Nosiska, D., Grillmayr, H., Schlusche, C., & Schabmann, A. (2000). Empowering diabetes out-patients with structured education: Short-term and long-term effects of functional insulin treatment on perceived control over diabetes. Journal of Psychosomatic Research, 48(1), 37–44.PubMedCrossRef

35.

Hirsch, A., Bartholomae, C., & Volmer, T. (2000). Dimensions of quality of life in people with non-insulin-dependent diabetes. Quality of Life Research, 9(2), 207–218.PubMedCrossRef

36.

Petterson, T., Lee, P., Hollis, S., Young, B., Newton, P., & Dornan, T. (1998). Well-being and treatment satisfaction in older people with diabetes. Diabetes Care, 21(6), 930–935.PubMedCrossRef

37.

Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E., Wolffenbuttel, B. H., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with Type 2 diabetes. Diabetes Care, 25(3), 458–463.PubMedCrossRef

38.

Marra, G., & DIAB. & TE.S Project Study Group. (2004). The DIAB. & TE.S Project: How patients perceive diabetes and diabetes therapy. Acta Bio-Medica: Atenei Parmensis, 75(3), 164–170.

39.

Brod, M., Skovlund, S. E., & Wittrup-Jensen, K. U. (2006). Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Quality of Life Research, 15(3), 481–491.PubMedCrossRef

40.

Cowie, C. C., & Eberhardt, M. S. (1995). Sociodemographic characteristics of persons with diabetes. In National Diabetes Data Group, National Institutes of Health, & National Institute of Diabetes and Digestive and Kidney Diseases (Eds.), Diabetes in America (pp. 85–116, 2nd ed.).

Titel: Reliability and validity of an instrument for assessing patients’ perceptions about medications for diabetes: the PAM-D
verfasst von: Patrick O. Monahan
Kathleen A. Lane
Risa P. Hayes
Colleen A. McHorney
David G. Marrero
Publikationsdatum: 01.09.2009
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 7/2009
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-009-9510-2

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2009

Building PROMIS item banks: librarians as co-investigators

Confirmatory and exploratory factor analysis of the caregiver quality of life index-cancer with Turkish samples

Psychosocial adaptation status and health-related quality of life among older Chinese adults with visual disorders

Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

Measuring pain in the context of homelessness

Quality of life from the perspective of adolescents with cerebral palsy: “I just think I’m a normal kid, I just happen to have a disability”